ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daly, R. C.
Right arrow Articles by Colby, T. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daly, R. C.
Right arrow Articles by Colby, T. V.

The Annals of Thoracic Surgery, Vol 51, 368-376, Copyright © 1991 by The Society of Thoracic Surgeons


ARTICLES

Bronchoalveolar carcinoma: factors affecting survival

RC Daly, VF Trastek, PC Pairolero, PA Murtaugh, MS Huang, MS Allen and TV Colby
Section of General Thoracic Surgery, Mayo Clinic, Rochester, Minnesota 55905.

One hundred thirty-four consecutive patients (65 men and 69 women) underwent pulmonary resection for bronchoalveolar carcinoma. Mean age was 65 years. Lobectomy was done in 100 patients, pneumonectomy in 10, segmentectomy in 5, and wedge excision in 19. Only 10 patients had lymph node metastases (7.5%). The neoplasm was solitary in 111 patients (82.8%); 97 were in stage I, 4 were in stage II, 9 were in stage IIIa, and 1 was in stage IIIb. There were two operative deaths (1.5%). Thirty- nine complications occurred in 31 patients. Median follow-up was 5.1 years. Recurrent bronchoalveolar carcinoma developed in 45 patients. Five- and 10-year survival for patients in stage I was 75.2% and 62.0%, respectively. Survival for patients with T1 N0 M0 neoplasms was identical to expected survival and was 90.5% at 5 years, as compared with 55.4% for patients with T2 N0 M0 disease, only 35.9% for patients with multiple bilateral disease, and 0.0% for patients with bilateral disease (p less than 0.0001). Other significant factors adversely affecting survival included the presence of signs and symptoms, diffuse malignant invasion, mucin-producing tumors, and the histological absence of scar. We conclude that bronchoalveolar carcinoma has a unique natural history that is more influenced by local neoplastic processes than by lymph node metastases. Early aggressive pulmonary resection is safe and offers the potential for cure. The presence of bilateral cancer, however, is ominous.


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
D Patsios, H C Roberts, N S Paul, T Chung, S J Herman, A Pereira, and G Weisbrod
Pictorial review of the many faces of bronchioloalveolar cell carcinoma
Br. J. Radiol., December 1, 2007; 80(960): 1015 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver
Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
Ann. Onc., August 1, 2006; 17(8): 1255 - 1262.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. D. Travis, K. Garg, W. A. Franklin, I. I. Wistuba, B. Sabloff, M. Noguchi, R. Kakinuma, M. Zakowski, M. Ginsberg, R. Padera, et al.
Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar Carcinoma
J. Clin. Oncol., May 10, 2005; 23(14): 3279 - 3287.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
S. I. Hajdu
The Story of Bronchioloalveolar Carcinoma
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 336 - 338.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Sakurai, Y. Dobashi, E. Mizutani, H. Matsubara, S. Suzuki, K. Takano, S. Shindo, and M. Matsumoto
Bronchioloalveolar Carcinoma of the Lung 3 Centimeters or Less in Diameter: A Prognostic Assessment
Ann. Thorac. Surg., November 1, 2004; 78(5): 1728 - 1733.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. S. Friedberg, C. Skema, J. Burdick, A. G. Yodh, S. R. Carr, and J. P. Culver
A novel technique for light delivery through branched or bent anatomic structures
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1963 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Barlesi, C. Doddoli, C. Gimenez, B. Chetaille, R. Giudicelli, P. Fuentes, J.-P. Kleisbauer, and P. Thomas
Bronchioloalveolar carcinoma: myths and realities in the surgical management
Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 159 - 164.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Wislez, M.-A. Massiani, B. Milleron, A. Souidi, M.-F. Carette, M. Antoine, and J. Cadranel
Clinical Characteristics of Pneumonic-Type Adenocarcinoma of the Lung
Chest, June 1, 2003; 123(6): 1868 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. I. Ebright, M. F. Zakowski, J. Martin, E. S. Venkatraman, V. A. Miller, M. S. Bains, R. J. Downey, R. J. Korst, M. G. Kris, and V. W. Rusch
Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma
Ann. Thorac. Surg., November 1, 2002; 74(5): 1640 - 1647.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
F. Darvishian, B. Roberts, S. Teichberg, and S. I. Hajdu
Ultrastructural Comparison of "Alveolar" and "Solid" Areas in Bronchioloalveolar Carcinoma
Ann. Clin. Lab. Sci., July 1, 2002; 32(3): 225 - 230.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Barlesi, C. Doddoli, P. Thomas, J.-P. Kleisbauer, R. Giudicelli, and P. Fuentes
Bilateral bronchioloalveolar lung carcinoma: is there a place for palliative pneumonectomy?
Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1113 - 1116.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Carretta, B. Canneto, G. Calori, G. L. Ceresoli, E. Campagnoli, G. Arrigoni, A. Vagani, and P. Zannini
Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma
Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 367 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Okubo, E. J. Mark, D. Flieder, J. C. Wain, C. D. Wright, A. C. Moncure, H. C. Grillo, and D. J. Mathisen
BRONCHOALVEOLAR CARCINOMA: CLINICAL, RADIOLOGIC, AND PATHOLOGIC FACTORS AND SURVIVAL
J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 702 - 709.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. R. Johnston, R. F. Minchen, and C. A. Dawson
LUNG PERFUSION WITH CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE METASTATIC SARCOMA TO THE LUNG OR DIFFUSE BRONCHIOLOALVEOLAR CARCINOMA
J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 368 - 373.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C.-P. Hsu, C.-Y. Chen, and N.-Y. Hsu
BRONCHIOLOALVEOLAR CARCINOMA
J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 374 - 381.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The Society of Thoracic Surgeons.